LifeStance Health LFST
$13.82 +$0.48 (+3.60%)
Market closed · Nov 22, 5:30 am ET · Last extended-hours $13.19 -4.59%
Open$13.21
Prev close$13.34
Day range$13.21 – $13.83
Volume5.62M
Market cap$5.25B
P/E (TTM)76.8
Dividend yield–
LFST Stock News
Headlines matching LifeStance Health or the LFST ticker, most recent first.
- CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15 Positive
- Jefferies Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15 Positive
- Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15 Positive
- BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $16
- CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13
- Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13 Positive
- A Quick Look at Today's Ratings for LifeStance Health(LFST.US), With a Forecast Between $13 to $16
- William Blair Maintains LifeStance Health(LFST.US) With Buy Rating
- BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $18 Positive
- J.P. Morgan Maintains LifeStance Health(LFST.US) With Hold Rating, Raises Target Price to $13 Positive
- J.P. Morgan Sticks to Its Hold Rating for Lifestance Health Group (LFST)
- Morgan Stanley Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13
- Barclays Maintains LifeStance Health(LFST.US) With Buy Rating, Maintains Target Price $13
- BTIG Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $15 Positive
- CCORF Maintains LifeStance Health(LFST.US) With Buy Rating, Raises Target Price to $13 Positive
No comments yet — be the first to weigh in on LFST.
Sign in to join the discussion.